101 related articles for article (PubMed ID: 2142007)
1. [An analysis of the hypothermic action of 8-hydroxy-2-(di-N-propylamino)tetralin, 1-(2-pyrimidinyl)piperazine and its derivatives].
Komissarov IV; Dolzhenko AT; Obraztsova OG; Zin'kovskaia LIa
Biull Eksp Biol Med; 1990 Mar; 109(3):275-7. PubMed ID: 2142007
[TBL] [Abstract][Full Text] [Related]
2. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
[TBL] [Abstract][Full Text] [Related]
3. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
4. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.
Zuideveld KP; Rusiç-Pavletiç J; Maas HJ; Peletier LA; Van der Graaf PH; Danhof M
J Pharmacol Exp Ther; 2002 Dec; 303(3):1130-7. PubMed ID: 12438536
[TBL] [Abstract][Full Text] [Related]
6. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
7. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function.
Goodwin GM; De Souza RJ; Green AR
Neuropharmacology; 1985 Dec; 24(12):1187-94. PubMed ID: 2869435
[TBL] [Abstract][Full Text] [Related]
8. Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion.
Hutson PH; Donohoe TP; Curzon G
Eur J Pharmacol; 1987 Nov; 143(2):221-8. PubMed ID: 2961583
[TBL] [Abstract][Full Text] [Related]
9. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
10. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.
Dursun SM; Handley SL
Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Goodwin GM; De Souza RJ; Green AR; Heal DJ
Psychopharmacology (Berl); 1987; 91(4):506-11. PubMed ID: 2954179
[TBL] [Abstract][Full Text] [Related]
12. 1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.
Martin P
Psychopharmacology (Berl); 1991; 104(2):275-8. PubMed ID: 1678895
[TBL] [Abstract][Full Text] [Related]
13. Selective activation of 5HT1A receptors induces lower lip retraction in the rat.
Berendsen HH; Jenck F; Broekkamp CL
Pharmacol Biochem Behav; 1989 Aug; 33(4):821-7. PubMed ID: 2533357
[TBL] [Abstract][Full Text] [Related]
14. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
Fuller RW; Perry KW
J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515
[TBL] [Abstract][Full Text] [Related]
15. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
Davis M; Cassella JV; Kehne JH
Psychopharmacology (Berl); 1988; 94(1):14-20. PubMed ID: 2894698
[TBL] [Abstract][Full Text] [Related]
16. Three putative 5-HT1A agonists act as 5-HT antagonists in frog sensory neurons.
Marszalec W; Anderson EG
Eur J Pharmacol; 1988 Sep; 154(3):325-8. PubMed ID: 2976672
[TBL] [Abstract][Full Text] [Related]
17. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
Fletcher PJ; Davies M
Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
[TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics.
Cunningham KA; Callahan PM; Appel JB
Eur J Pharmacol; 1987 Jun; 138(1):29-36. PubMed ID: 2887435
[TBL] [Abstract][Full Text] [Related]
19. Gonadal hormones affect the hypothermia induced by serotonin1A (5-HT1A) receptor activation.
Matsuda T; Nakano Y; Kanda T; Iwata H; Baba A
Life Sci; 1991; 48(17):1627-32. PubMed ID: 1826754
[TBL] [Abstract][Full Text] [Related]
20. Selective increase in carbohydrate intake by rats treated with 8-hydroxy-2-(di-n-propylamino)-tetraline or buspirone.
Luo SQ; Ransom T; Li ET
Life Sci; 1990; 46(23):1643-8. PubMed ID: 2141379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
